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Chronic respiratory diseases are a major cause of morbidity and mortality in Canada. According to statistics from the 
Public Health Agency of Canada in 2008, 847,000 Canadians 
35 years of age or older self-reported a diagnosis of chronic 
obstructive pulmonary disease (COPD) (1). COPD is esti-
mated to affect as many as three million Canadians including 
approximately 1.6 million who are undiagnosed (2). Recent 
population studies (3) have documented a COPD prevalence 
of 17% to 20% of the population, and values approaching 50% 
in the elderly. COPD is associated with a rising mortality rate 
and is the only common cause of death with this distinction. It 
is projected to be the third leading cause of death in Canada 
and worldwide by 2020 (4). A recent report on the burden of 
COPD to Canada’s health system (5) showed that COPD was 
the most common cause of admission and readmission to hos-
pital compared with other chronic diseases. However, aware-
ness of COPD was found to be as low as 17% among Canadians 
when compared with awareness of other major diseases such as 
breast cancer (95%), HIV/AIDS (95%) and Alzheimer’s dis-
ease (94%) in a Canadian COPD awareness assessment com-
pleted in 2005 (6). Smoking remains the single most significant 
cause of COPD, and smoking cessation is the most effective 
means of reducing the risk of developing the disease or slowing 
its progression (7,8). 
Lung cancer is the leading cause of cancer death in Canada. 
Similar to COPD, it is strongly linked to tobacco use, making 
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OBJECTIVE: To assess awareness among persons at risk for lung cancer, 
chronic obstructive pulmonary disease (COPD) and sleep apnea regarding 
symptoms and risk factors of the disease, and their attitudes regarding the 
disease and toward those who are affected.
METHODS: A quantitative hybrid telephone and Internet survey of a 
representative population of Canadian adults at risk for at least one of the 
three diseases was conducted. To measure the awareness and attitudes of 
First Nations, Inuit and Métis people to these diseases, a proportionate 
number were also surveyed.
RESULTS: A total of 3626 individuals were contacted. Of these, 3036 (84%) 
were eligible to participate. Of those at risk for lung cancer and COPD, 65% 
and 69%, respectively, were due to tobacco smoke exposure. Among those 
at risk, 72% believed that they were informed about lung cancer compared 
with 36% for COPD and 56% for sleep apnea. Most respondents were 
knowledgeable about the common symptoms of lung cancer, COPD and 
sleep apnea, but were less aware of the impact lifestyle choices could have 
on the development of these disorders and the availability of treatment. 
Most of the participants (77%) believed that smoking was an addiction 
rather than a habit (19%). There were no significant differences in the 
awareness of risk factors, symptoms and attitudes toward all three lung 
diseases between First Nations, Inuit and Métis people and the general 
population.
CONCLUSIONS: Canadians are reasonably aware of risk factors and 
symptoms for lung cancer and sleep apnea. However, there is poor aware-
ness of COPD as a disease entity. There is a lack of appreciation for the 
impact lifestyle choices and changes can have on lung diseases. 
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La sensibilisation aux facteurs de risque chez les 
personnes vulnérables au cancer du poumon, à la 
maladie pulmonaire obstructive chronique et à l’apnée 
du sommeil : Une étude canadienne en population
OBJECTIF : Évaluer la sensibilisation des personnes vulnérables au cancer 
du poumon, à la maladie pulmonaire obstructive chronique (MPOC) et à 
l’apnée du sommeil aux symptômes et facteurs de risque de la maladie ainsi 
que leurs attitudes au sujet de la maladie et des personnes qui en sont 
atteintes.
MÉTHODOLOGIE : Les chercheurs ont mené une enquête téléphonique 
hybride par téléphone et par Internet auprès d’une population représenta-
tive d’adultes canadiens vulnérables à au moins l’une des trois maladies. 
Pour mesurer la sensibilisation et les attitudes des populations inuites, 
métisses et des Premières nations, ils ont également sondé un nombre pro-
portionnel de cette population.
RÉSULTATS : Au total, les chercheurs ont communiqué avec 3 626 per-
sonnes. De ce nombre, 3 036 (84 %) étaient admissibles à participer. Parmi 
les personnes vulnérables au cancer du poumon et à la MPOC, 65 % et 69 %, 
respectivement, l’étaient en raison d’une exposition à la fumée du tabac, 
Chez les personnes vulnérables, 72 % pensaient être informées à l’égard du 
cancer du poumon, par rapport à 36 % à l’égard de la MPOC et à 56 % à 
l’égard de l’apnée du sommeil. La plupart des répondants connaissaient les 
symptômes courants du cancer du poumon, de la MPOC et de l’apnée du 
sommeil, mais moins les répercussions possibles des choix relatifs au mode 
de vie sur l’apparition de ces troubles et la disponibilité du traitement. La 
plupart des participants (77 %) pensaient que le tabagisme était une intoxi-
cation plutôt qu’une habitude (19 %). Il n’y avait pas de différences signifi-
catives quant à la sensibilisation aux facteurs de risques, aux symptômes et 
aux attitudes envers les trois maladies pulmonaires entre les populations 
inuites, métisses et des Premières nations et l’ensemble de la population.
CONCLUSIONS : Les Canadiens sont raisonnablement au courant des 
facteurs de risque et des symptômes de cancer du poumon et d’apnée du 
sommeil. Cependant, ils sont peu sensibilisés à la MPOC comme entité 
pathologique et sont peu conscients des répercussions des choix relatifs au 
mode de vie et des modifications qui y sont apportées sur les maladies 
pulmonaires.
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it one of the most preventable malignancies. Awareness of the 
risk factors for various types of cancer among the general popu-
lation has been studied in many countries (9-11). The public 
appears to be aware of smoking as a risk for cancer, but they are 
far less perceptive about the role of other modifiable lifestyle 
factors such as obesity, physical activity and diet (12,13). To 
date, there is insufficient evidence to support the regular screen-
ing of individuals considered to be at high risk for developing 
lung cancer, further emphasizing the need for primary preven-
tion and recognition of disease symptoms (14).  
It is estimated that as many as 24% of middle-age adult men 
and 9% of women experience sleep-disordered breathing, while 
2% of middle-age women and 4% of men have sleep apnea 
(15). People who are affected by sleep apnea are often not 
aware of their disease. Undiagnosed sleep apnea can lead to 
serious health and economic sequelae including an increased 
risk for heart attack, high blood pressure, stroke, depression, 
memory difficulties and excessive daytime sleepiness, with 
adverse personal and occupational outcomes. There is also an 
increased risk of motor vehicle accidents, especially those 
involving personal injury (16).
The aim of the present survey was to study a representative 
sample of the Canadian population for lung cancer, COPD and 
sleep apnea to better understand how persons at risk for these 
diseases perceived symptoms and risk factors of the disease. In 
addition, attitudes regarding the disease and toward those who 
suffer from it were examined. We also explored the perspec-
tives of Canadians who are at risk for these diseases with 
respect to the lifestyle choices that put them at risk for disease 
and the options they have for decreasing their chances of being 
affected by these disorders.
METHODS
The Canadian Lung Association (CLA) presented the current 
study proposal to the National Lung Health Framework to 
explore self-awareness of risk factors for major lung diseases in 
Canada in a population group most at risk.  
Table 1 lists a series of risk factors that were defined by the 
CLA Advisory Committee to identify persons at risk for lung 
cancer, COPD and sleep apnea. 
A quantitative survey was subsequently developed and con-
ducted among Canadians with at least one of the identified risk 
factors.  
To ensure that a representative sample of the Canadian 
population was included in the present study, the survey was 
conducted using a hybrid of telephone and Internet surveys. 
The survey was performed by an experienced contractor (Leger 
Marketing, Canada). A sample size of 3000 was estimated to be 
sufficient to obtain a margin of error of 5% or less. The tele-
phone and Internet surveys commenced on April 12 and 16, 
2010, respectively, and both were completed on April 28, 
2010. 
Survey field staff received in-depth training before proceed-
ing to a practice phase. During practice sessions, interviewers 
worked with one another to role-play a simulated survey. 
Interviewing was allowed to commence only when the super-
visor was satisfied that each interviewer was able to conduct a 
proper, professional interview. Intensive monitoring, editing 
and verification were conducted throughout the field process 
in accordance with the standards of the Market Research and 
Intelligence Association (17). 
Respondents were classified as being at risk for lung cancer, 
COPD or sleep apnea according to their responses to the sur-
vey questions. If a respondent had no risk factors identified at 
initial questioning, the survey was ended; these persons were 
not included in the study results. Due to the length of the sur-
vey, once risks were determined, each participant was only 
asked questions about one disease for which they were at risk. 
If they were at risk for more than one of the three diseases, they 
were questioned about the disorder for which they had the 
most risk factors. If the number of risk factors was equal, they 
were randomly selected to receive questions about only one of 
the diseases, with quotas to ensure that all three diseases 
received representation.
While it was important that the study be representative of 
the Canadian population as a whole, it was necessary to under-
stand the attitudes and perceptions of the First Nations, Inuit 
and Métis people (FNIMP). For this reason, a higher than pro-
portionate number of FNIMP were surveyed (115 in total). 
The results of this cohort were analyzed separately, but 
weighted against the entire sample population to ensure that 
they were representative of the Canadian population so as to 
not introduce bias with regard to the FNIMP population.
RESULTS
The risk factors used to define the three risk groups are shown 
in Table 1. A total of 3626 participants were contacted and 
agreed to participate in the study. Of these, 403 did not qualify 
for the survey because they were not at risk for any of the dis-
eases being studied; 10 were younger than 18 years of age and 
therefore, were not eligible; and 170 were eligible but refused 
to participate, resulting in 3036 participants (84%) who com-
pleted the survey. The 3036 respondents were representative of 
the Canadian population. The characteristics of the survey 
participants are shown in Table 2. 
Table 1
Factors used to define the risk groups (lung cancer, 
chronic obstructive pulmonary disease [COPD] and sleep 
apnea)
Risk factor
Risk group
lung cancer COPD Sleep apnea
Smoking   
Exposure to secondhand smoke   
Past smoker   
Exposure to dust or chemicals  
Exposure to asbestos or radon 
Personal history   
Family history   
Frequent, long-lasting chest  
infections
 
Chronic cough  
Shortness of breath/wheezing  
Severe or untreated asthma 
Obesity 
Swollen tonsils/adenoids 
Chronic bronchitis  
Snoring 
Thick neck or small jaw 
Exposure to smoke from wood 
stoves

awareness of risk factors for lung diseases
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Lung cancer awareness
A total of 980 of those surveyed were at risk for lung cancer. 
Forty-six per cent of the participants had at least one risk fac-
tor for lung cancer; 32% had two and 23% had three or more. 
Sixty-five per cent of those at risk were due to tobacco smoke 
exposure (27% current smokers, 29% past smokers and 9% sec-
ondhand smoke [SHS] exposure). Nearly one-half (48%) claimed 
exposure to dust, chemicals, asbestos or radon. Seventy-two 
per cent either knew a little (52%) or a lot (20%) about the 
causes, symptoms and treatment of lung cancer. Smokers were 
less aware of the symptoms of lung cancer than nonsmokers 
(Tables 3 and 4). Most participants considered tobacco expos-
ure to be a primary cause of lung cancer; however, occasional 
tobacco smoke and marijuana smoke use was believed to be 
a less likely cause. Cigarillo use was believed by the major-
ity (61%) of respondents to be as risky as smoking cigarettes. 
Seventy-four per cent of subjects believed that asbestos expos-
ure was a cause of lung cancer, but only 49% believed radon 
exposure was a risk factor. 
Smokers were less likely to believe that there was a con-
tinued risk for lung cancer if they quit smoking, and more likely 
to believe their body would be healthy again if they quit. 
However, smokers were more likely to believe that there was no 
way to control the risk of cancer than nonsmokers (current smoker 
20% [95% CI 13.75% to 26.25%]; past smoker 11% [95% CI 6% 
to 17%]; never smoked 13% [95% CI 7.8% to 18.2%]). 
Table 2
Characteristics of the survey participants
Characteristic Total
Risk group
lung  
cancer COPD
Sleep  
apnea
Region
   Alberta 8 8 8 8 
   Manitoba 4 4 4 4 
   New Brunswick 2 2 2 2 
   British Columbia 9 9 9 9 
   Quebec 29 29 29 29 
   Prince Edward Island 1 1 1 1 
   Saskatchewan 5 5 4 5 
   Newfoundland and Labrador 2 1 2 2 
   Ontario 38 37 37 37 
   Nova Scotia 3 3 3 3 
   Northwest Territories <1 <1 <1 <1 
Type of community
   Urban    64 62 62 64 
   Rural  37 38 39 37 
Male sex 50 50 50 51 
Age, years
   18–34 18 18 19 17 
   35–44 15 14 14 14 
   45–54 23 24 24 24 
   55–64 23 24 24 24 
   ≥65 20 20 19 21 
Yearly income, $
   <40,000 23 24 24 22 
   40,000 to 79,000 32 33 33 32 
   ≥$80,000 26 25 25 27 
Employment
   Full time 45 44 44 45 
   Part time 10 10 10 10 
   Homemaker 5 5 5 5 
   Student 6 6 6 5 
   Retired 29 30 29 30 
   Between jobs 4 4 4 3 
Marital status
   Married/common-law 65 64 64 67 
   Divorced or separated 10 11 11 10 
   Widowed 5 5 5 5 
   Single 19 19 19 17 
Education
   Less than high school 29 30 31 29 
   College 32 33 33 32 
   Undergraduate degree 23 22 21 22 
   Graduate degree 15 14 13 15 
Data presented as %. COPD Chronic obstructive pulmonary disease
Table 3
awareness levels of lung cancer symptoms: Smokers 
versus nonsmokers
Symptom
Smoking exposure, %
Current  
(n=275)
Past  
(n=395)
Never  
(n=301)
Cough persists or gets worse 74 79 81**
Coughing up blood 74 79 80
Being short of breath 75 79 79
Long-lasting chest infections 61 65 74**
Feeling tired 59 67* 70**
Wheezing 66 67 68
Getting lots of chest infections 57 58 67**
Losing weight without trying 50 64** 61**
Ongoing pain in back or  
shoulder
38 41 44
Losing your voice 37 32 35
Swollen neck or face 27 23 27
Question asked: ‘Please tell me if you think each thing on this list is a symptom 
of lung cancer’. Base: Those at risk for lung cancer (n=980). *Denotes signifi-
cant difference at P=0.05; **Denotes significant difference at P=0.01
Table 4
awareness levels of lung cancer causes: Smokers versus 
nonsmokers
Cause
Smoking exposure, %
Current  
(n=275)
Past  
(n=395)
Never 
(n=301)
Smoke a pack per day for 10 years or 
more
70 78* 88**
Near secondhand smoke 53 69** 77**
Exposed to asbestos 66 77** 76**
Smoking one pack per day for 10 years, 
but quitting 5 or more years previously
38 39 66**
Exposed to dust or chemicals 51 66** 63**
Family history of lung cancer 53 49 54
Smoking marijuana 30 50** 54**
Exposed to radon 44 50 51
Smoking (occasionally)
   Cigarillos 31 44** 51**
   Cigarettes 33 46** 49**
   Marijuana 18 30** 27**
Question: Base: ‘I am going to read a list of things. I want you to tell me if these 
things could cause lung cancer.’ Base: Those at risk for lung cancer (n=980). 
*Denotes significant difference at P=0.05; **Denotes significant difference at 
P=0.01
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Fifty per cent of persons at risk for lung cancer believed that 
if one had been a heavy smoker and quit, there was still a high 
risk of lung cancer, while only 9% disagreed and 35% were 
neutral. Only 25% of persons responded that once one had quit 
smoking for a few years, the body would then be healthy again. 
Sixty-one per cent of respondents disagreed with the statement 
“People won’t get lung cancer if they don’t smoke and if they 
stay away from second-hand smoke”, while only 11% agreed.
Twenty-three per cent of respondents believed that, because 
of smoking, patients were responsible for having developed 
lung cancer, while 39% disagreed. Only 21% of respondents 
believed that there was a negative stigma attached to, and dis-
crimination toward, people with lung cancer. While current 
smokers (27% [95% CI 21% to 33%]) were more likely to 
believe that there was negative stigma toward lung cancer 
patients than past smokers (19% [95% CI 14% to 24%]) or 
those who had never smoked (20% [95% CI 14.8% to 25.2%]), 
smoking behaviour did not appear to affect the likelihood of 
believing that lung cancer patients were responsible for their 
disease. Only a minority (18%) of those at risk for lung cancer 
agreed that there was no real treatment to help someone with 
lung cancer, while 41% disagreed.
COPD awareness
Persons at risk for COPD were surveyed if they had one or 
more of the risk factors or symptoms listed in Table 1. A total 
of 868 persons surveyed were found to have at least one risk 
factor for COPD. No persons were found to be at risk for 
COPD only; they were also found to be at risk for lung cancer 
or sleep apnea or, more often, both. Of those found to be at risk 
for COPD, 69% were due to exposure to tobacco smoke: cur-
rent smoker (29%), past smoker (30%) or SHS exposure 
(10%). Other documented exposures were past (24%) and cur-
rent (12%) marijuana use, and indoor wood smoke (14%). 
More than one-half of persons experienced exposure to dusts or 
chemicals at work. Only a small proportion of Canadians – 
10% or less – noted a family history of lung disease or COPD as 
a risk factor.
Assessing knowledge about COPD was challenging because 
not all persons at risk for COPD were aware of the disease ter-
minology ‘COPD’ or ‘chronic obstructive pulmonary disease’. 
This, in fact, was the case with 13% of the respondents in the 
present cohort, who were then asked about the condition using 
one of the other names associated with COPD such as ‘emphy-
sema’ or ‘chronic bronchitis’. Only 39% (approximately two-
fifths) of persons at risk for COPD knew at least a little or a lot 
about the disease by any of its three names, but the remaining 
60% of persons at risk for COPD, knew very little to nothing 
about the disease (Table 4). Women and older individuals 
seemed to be more knowledgeable about the disease (women 
39% [95% CI 34.3% to 43.7%] versus men 32% [95% CI 
27.3% to 36.7%]; 55 years of age or older 42% [95% CI 36.8% 
to 47.2%] versus younger than 55 years of age 31% [95% CI 
26.7% to 35.3%]). Smokers (current 43% [95% CI 36.6% to 
49.4%] and past 39% [95% CI 33.8% to 44.2%]) claimed to 
have more knowledge than nonsmokers (27% [95% CI 21.1% 
to 32.9%]).
Canadians at risk for COPD appeared to appreciate the 
major symptoms associated with COPD. More than 60% iden-
tified shortness of breath, wheezing, prolonged cough or pro-
longed chest infections as being possible symptoms of COPD. 
There appeared to be no difference in knowledge about symp-
toms of COPD between smokers and nonsmokers. However, 
27% of persons either did not know (22%) or did not agree 
(5%) that smoking a pack of cigarettes per day for 10 years or 
more was a potential cause of COPD. One-quarter of the 
respondents were further uncertain about the risk associated 
with marijuana or cigarillo use, SHS exposure or smoking 
intermittently as potential causes of COPD. Approximately 
one-third of persons expressed that, despite someone quitting 
smoking, there remained a risk for developing the disease, but 
many more were uncertain (31%) or just did not know (24%). 
Persons at risk for COPD were asked about other exposures, 
and perceived that exposure to dust or chemicals (53% positive 
response), family history (43%) or personal history of asthma 
(40%) were more likely causes of COPD than exposure to 
marijuana smoke (17% positive response), wood smoke (34%) 
or occasional tobacco smoke (29%).
There was low awareness of personal responsibility for the 
risk of COPD. Although 36% of persons believed that if one had 
been a heavy smoker and quit, there still was a high risk for the 
disease, 35% disagreed or did not know and 29% expressed 
neutrality. Slightly less than one-half of persons at risk for 
COPD did not know or did not believe that there was an avail-
able treatment for COPD. Only 12% of responders believed 
that there was negative stigma associated with COPD, but a 
larger proportion did not know or expressed neutrality (33% 
and 28%, respectively). 
Sleep apnea awareness
Of the 3036 eligible persons who completed the survey, 1174 were 
found to be at risk for sleep apnea. Individuals were identified 
as being at risk for sleep apnea if they had one or more of the 
following risk factors: snoring, family history, a thick neck or 
small jaw, obesity, swollen adenoids or tonsils, or a personal 
diagnosis of sleep apnea. A total of 155 persons with any form of 
tobacco or alternative smoke exposure as their only risk factor 
were also included in this sleep apnea cohort. More than one-
half of those at risk for sleep apnea were identified because of 
snoring (58%). Fifty-eight per cent of those in this risk group 
experienced tobacco exposure. However, only 27% (99% CI 
23.2% to 30.8%) of those at risk for sleep apnea believed that 
smoking was a risk factor for sleep apnea compared with 70% 
(99% CI 65.9% to 74.1%) and 62% (99% CI 57.6% to 66.4%) 
who believed that smoking was a cause of lung cancer or 
COPD, respectively. Twenty per cent of persons identified a 
positive family history, while 8% had a personal history of the 
Table 4
awareness levels of chronic obstructive pulmonary 
disease (COPD), emphysema or chronic bronchitis
awareness COPD emphysema
COPD, emphysema 
or chronic bronchitis
Know a lot 9 1 9
Know a little 27 25 30
I don’t know much 23 31 28
I don’t know anything 28 29 32
Never heard of (the disease 
listed in column heading)
13 14 <1
Data presented as %
awareness of risk factors for lung diseases
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disease. Only 12% were obese, but 17% admitted to having a 
thick neck or small jaw, and 11% had swollen tonsils or aden-
oids. Twenty-seven per cent of persons had three or more risk 
factors for sleep apnea.
Knowledge of the disease, symptoms and treatment were 
expressed by 56% of those at risk for sleep apnea. Although 
men are at a greater risk for sleep apnea, women appeared to 
have more overall knowledge than men (women 64% [99% CI 
58.7% to  69.3%] versus men 48% [99% CI 42.6% to 53.4%]), 
as were those who were older (99% CI 54.9% to 63.1%) or had 
more than two risk factors for sleep apnea (99% CI 45.9% to 
56.1%). Greater than 60% of those at risk for sleep apnea iden-
tified the major symptoms associated with sleep apnea such as 
not feeling rested, heavy snoring, daytime sleepiness, or chok-
ing or gasping during sleep; however, other phenomena occa-
sionally associated with sleep apnea, such as morning headaches, 
depression, high blood pressure or impotence, were less well 
recognized. While one-half of persons at risk for sleep apnea 
believed that being overweight or a heavy snorer were possible 
causes of the disease, many were unsure of other medical causes 
that may cause sleep apnea, and were more likely to believe 
that asthma was a potential cause compared with swollen ton-
sils, large neck size or an underdeveloped jaw. 
Sixty-six per cent of persons at risk for sleep apnea believed 
that the disease was a serious condition that needed treatment. 
Forty per cent were aware that using a breathing machine at 
night would help treat the disease. A significant number of 
participants did not agree that sufferers were responsible for 
their disease symptoms because they were overweight (57%) or 
that they just needed to exercise more (46%). 
Tobacco exposure
All participants at risk for the three selected diseases were ques-
tioned about their attitudes toward smoking and tobacco expos-
ure. Most respondents (77%) believed that smoking was an 
addiction rather than a habit (19%), and that it was very diffi-
cult to quit. This viewpoint was shared equally among smokers 
(80%), nonsmokers (75%) and ex-smokers (76%) (P value non-
significant at 95% level of confidence). Older persons (95% CI 
76.8% to 81.2%), higher income individuals (99% CI 76.1% to 
89.1%), women (99% CI 75.7% to 82.3%) and nonsingle per-
sons (99% CI 75.4% to 80.6%) shared this viewpoint more so 
than others.
Sixty-one per cent of those surveyed experienced current or 
previous tobacco exposure. Twenty-two per cent of the studied 
population were current cigarette smokers, 14% smoked regu-
larly and 8% smoked intermittently. Thirty-nine per cent had 
previously smoked but had quit, while another 39% had never 
smoked cigarettes or other tobacco products. The highest preva-
lence of smoking was for individuals between the ages of 18 and 
34 years (33% [95% CI 25.8% to 40.2%]), FNIMP (31% [95% 
CI 24.2% to 37.8%]) and single persons (30% [95% CI 25.9% to 
34.1%]). Some regional differences were seen across the country, 
with Quebec, Ontario and Alberta having the highest reported 
prevalences of smoking compared with the other provinces. 
Of those admitting to smoking regularly or occasionally, 
almost all mentioned that they smoked cigarettes (98%). 
Almost one-half (45%) of persons between 18 and 34 years of 
age smoked cigarillos, with 7% responding that they were current 
cigarillo smokers. Smoking frequency increased directionally 
with age. An average of 8.4 cigarettes per day were smoked in 
the group 18 to 34 years of age (95% CI 1.2 to 15.6 cigarettes 
per day) compared with a peak smoking frequency of 15.7 ciga-
rettes per day (95% CI 7.1 to 24.3 cigarettes per day) in the 
group 55 to 64 years of age.
Seventy per cent of smokers have discussed smoking issues 
with their doctor more so than with friends or family. This 
tendency increased directionally with age (18 to 34 years, 99% 
CI 41.6% to 60.4% versus 35 years of age and older, 99% CI 
69.3% to 80.7%). Women (95% CI 64.3% to 76.5%) or those 
who were currently or previously married (99% CI 66.3% to 
77.7%) were more likely to speak to their doctor about smok-
ing than men or single persons. The type of discussion mostly 
concerned options to help them quit (67%) or the health risks 
associated with smoking (50%). Attitudes regarding smoking 
reflected some guilt regarding the habit and the appreciation of 
the risks associated with it. One-third of respondents believed 
that they were judged unfavourably because of their smoking 
habit. Approximately 60% of respondents did not agree with 
the statement “my smoking is none of my doctor’s business” or 
“I don’t think smoking is as bad as people say”. Only 10% were 
not responsive to a discussion about their habit with their doc-
tor and did not want to quit.
SHS
Six hundred eighty-five smokers were asked to indicate whether 
they smoked indoors or in a car, either in the presence of another 
adult who was a nonsmoker or a child. Thirty-five per cent 
smoked indoors when there was a nonsmoking adult present 
in the house, and 18% smoked in the house when a child was 
present (Table 5). Twenty-one per cent of respondents said they 
smoked in a car in the presence of an adult nonsmoker, and 8% 
smoked in cars with children on board. When asked whether 
they smoked in a car with other adults who smoked, 61% 
responded positively. Overall, 23% of the 3036 survey respond-
ents reported that someone in their household smoked.
Thirty-six per cent of current smokers reported that other 
smokers they lived with usually smoked inside, 65% of 
nonsmokers said that smokers in their home usually smoked 
inside and 56% of past smokers indicated that smokers in their 
home smoked inside (Table 6). Twenty-one per cent of past 
smokers and 13% of those who never smoked said they were 
subjected to smoke in a car at least once per week. Overall, 
more than one-third of nonsmokers are subjected to smoke 
at home or in a car. Smokers in Quebec were more likely to 
expose nonsmokers, either adults (59%) or children (37%), to 
SHS (99% CI 73.9% to 92.1%) than in any other province.
Table 5
Smoking locations among smokers
Smoking location Smokers, % 
Indoors when there is also a nonsmoking adult  
somewhere in the house
36
Indoors when there is also a child somewhere in the house 18
In a car when you are by yourself or with other people who 
smoke
61
In a car when you are with other people who do not smoke 21
In a car when you are with children 8
None of the above 31
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Other risk factors experienced by Canadians
Nine per cent of Canadians surveyed smoked marijuana regu-
larly or occasionally, while three in 10 smoked it daily. Twenty-
one per cent of current marijuana smokers were also tobacco 
smokers. Forty per cent of the surveyed population experienced 
exposure to at least one of asbestos, radon, workplace dust, or 
chemicals in their present or previous job. Twenty-nine per cent 
of persons were exposed to indoor smoke caused by a wood 
stove or fireplace at least once per month. However, when 
asked about the cleanliness of the air where they lived, 81% of 
Canadians believed that the air they breathed was clean.
FNIMP 
One hundred fifty-five FNIMP were surveyed, with the results 
weighted to ensure a true representation within the Canadian 
population. A higher prevalence of smoking was seen among 
FNIMP compared with the general population across Canada 
(31% [95% CI 24.2% to 37.8%] versus 22% [95% CI 20.1% to 
23.9%]). Analysis of the awareness of risk factors, symptoms 
and perceptions for the three studied lung diseases among 
FNIMP showed no significant difference when compared with 
the rest of the Canadian population. Attitudes toward health 
care also showed no statistical differences.  
Health care attitudes and behavioural changes
Exposure to tobacco smoke was believed by at-risk Canadians 
to be the most causative risk factor for lung cancer (79% [99% 
CI 74.9% to 83.2%]), more so than for COPD (62% [99% CI 
57.6% to 66.4%]) and significantly more so than for sleep 
apnea (27% [99% CI 23.2% to 30.8%]). There was very little 
stigma associated with any of these lung diseases. However, 
lung cancer had a somewhat more negative stigma than COPD 
or sleep apnea (21% versus 12% and 10%, respectively [99% 
CI]). More than 50% of Canadians were open to seeing their 
physician about health-related concerns. Only 15% would 
have preferentially asked their family or friends for health 
advice. Yet, less than one in five persons at risk for any of the 
lung diseases studied believed that they needed to take better 
care of themselves.  
DISCUSSION
COPD
The results of the present survey suggest a disturbingly low 
level of awareness of COPD among Canadians most at risk for 
this disease. Only 39% of persons at risk believed they had at 
least some knowledge of the symptoms, causes or treatment 
of COPD, but 60% knew little or nothing at all. The present 
survey also showed that the term ‘chronic obstructive pul-
monary disease’ and the acronym ‘COPD’ are still completely 
unknown to 13% of the Canadian population at risk. Although 
awareness of COPD remains low among the general Canadian 
population, there has been an improvement in awareness for 
the term ‘chronic obstructive pulmonary disease’ (45% improv-
ing to 59%) and the acronym ‘COPD’ (17% improving to 
33%) in survey results from 2005 compared with 2007 (2,6). 
Canadians at risk for COPD were predominantly so because 
of cigarette smoke exposure, which is clearly identifiable as the 
most significant risk factor for the development of this condi-
tion. Sixty-one per cent of the total survey population experi-
enced tobacco smoke exposure, with 69% of this particular 
at-risk subset being exposed. Although most of those surveyed 
in the present study were aware that cigarette smoke is a major 
risk factor for disease, 29% of persons at risk for developing 
COPD did not know or did not agree that the cause of COPD 
included tobacco smoke exposure. This lack of awareness may 
impair the motivation of at-risk individuals to consider smok-
ing cessation. It is not yet clear how many smokers will develop 
COPD, but current studies (18) suggest that at least 20% of smok-
ers or ex-smokers older than 40 years of age have airflow obstruc-
tion consistent with COPD, but only 30% were aware of a 
personal diagnosis of the disease. Study participants were even less 
aware of the risk of COPD from exposure to other factors such as 
marijuana smoke, wood smoke, dust and chemicals. Although less 
may be known about how significantly these exposures impact or 
add to the risk of tobacco on the development of COPD, they are 
likely contributors to the disease (19-21).
The present study revealed that persons at risk for COPD 
were neither confident nor aware that quitting smoking may 
help protect them from developing the disease. There is uncer-
tainty about who else may get the disease such as young persons, 
those who are exposed to alternative tobacco products or SHS or 
ex-smokers. It is also uncertain whether exercise is protective. 
Furthermore, those at risk were largely unsure of treatment 
options for COPD. This lack of knowledge may, in fact, diminish 
the personal responsibility for making healthy lifestyle choices 
or reducing personal risk for development of the disease.  
Lung cancer
A significant number of respondents in our study were able 
to identify the main symptoms of lung cancer. The Special 
Cancer Behavioral Risk Factor Survey (22) asked adults older 
than 40 years of age in the general population of Michigan (USA) 
to name the symptoms associated with lung cancer. Compared 
with our study, a persistent cough, bloody spit/phlegm and diffi-
culty breathing were reported by 53%, 27% and 55% of partici-
pants, respectively. Variations in risk perception for developing 
lung cancer among current smokers, former smokers and 
never smokers have been studied previously. Results from the 
National Lung Screening Trial (23) found that current smok-
ers and former smokers had different risk perceptions, with the 
latter group having a lower perceived risk for lung cancer. Similar 
to the results of our survey, a large national telephone survey study 
of smokers in the United States (US) (24) found that participants 
underestimated their risk of lung cancer compared with nonsmok-
ers. In another US national telephone survey (25), never smokers 
were more likely than current smokers to believe that early detec-
tion of lung cancer could improve their survival.
Table 6
Secondhand smoke exposure
Smoking habit, %
Current Past Non
Always smoke outside 40* 20* 13
Usually smoke outside, sometimes 
smoke inside
 24  25  22
Usually smoke inside  36 56* 65*
Question: ‘Where do the smokers you live with usually smoke?’ Base: n+705. 
*Denotes significance at P=0.01
awareness of risk factors for lung diseases
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Sleep apnea
Slightly more than 50% of persons with risk factors for sleep 
apnea believed that they had at least a little knowledge about 
the disease. Although they were aware of more common symp-
toms of the disease, they were less likely to link concentration 
problems, headaches, depression, high blood pressure or impo-
tence with the disease. This result suggests that there is a need 
for improved education among the public and primary care 
physicians to be aware of other presenting signs or symptoms of 
sleep apnea so as to better screen for this potentially prevalent 
disease. Women appeared to know more about the disease, 
although men are at greater risk – our results do not explain 
why this was the case.
Snoring and tobacco smoke exposure were the greatest risk 
factors for sleep apnea, with snoring being present in 58% of 
the cohort, many of whom had two or more risk factors. It is 
perhaps surprising to note that 51% of Canadians surveyed 
admitted that they snored loudly. This represents a large num-
ber of people who may be at risk for sleep apnea but, possibly, 
are not appreciated or diagnosed.
There is some uncertainty regarding all of the factors that 
may contribute to or cause sleep apnea, although being over-
weight was clearly identified as a risk. However, persons at risk 
for the condition did not believe that simply losing weight or 
exercising more would cure the problem. Therefore, this group 
was not sure how to reduce their risks or prevent this disease. 
However, persons at risk for sleep apnea recognized this as a 
serious disease that required treatment (72%), and many were 
aware of a potential treatment option.
Fifty-eight per cent of those at risk for sleep apnea were at 
risk due to smoking – the same proportion as for snoring. 
Smokers are almost three times more likely to have sleep apnea 
compared with former and never smokers (26). The mechan-
ism by which smoking could predispose to sleep apnea is not 
clear. It has been postulated that inflammatory changes caused 
by cigarette smoke, together with negative effects of nicotine 
withdrawal at night, may be important factors (27).
Smoking attitudes and behaviour
Canadians were, in large part, aware of the adverse role tobacco 
smoke may have on their health and their risk for developing 
certain diseases. They were less sure about the benefits that 
may result from smoking cessation. Furthermore, they were less 
aware of the risks associated with other tobacco products, or 
intermittent or SHS exposure. There is a continued necessity 
to prevent smoking, but there is also an opportunity to promote 
smoking cessation as a means of improving health and reducing 
risks factors for disease. This education still needs to permeate 
the general population. Seventy per cent of smokers have 
spoken to their family doctor about their habit, and the med-
ical community appears to be more of a source of health advice 
than family and friends. Here, again, is an opportunity to edu-
cate and change behaviour.
SHS
SHS is a significant risk to health and is a known carcinogen in 
humans. It is estimated that more than 1000 Canadians die 
each year from illnesses such as lung cancer, chronic respiratory 
diseases, coronary artery diseases and other disorders as a result 
of prolonged SHS exposure (28). Overall, our study showed 
that more than one-third of nonsmokers were subjected to 
smoke at home or in a car. The 2009 Canadian Tobacco use 
Monitoring Survey (29) found that 20% of Canadians older 
than 15 years of age were exposed to SHS at least once per 
month. Children are more vulnerable to the adverse effects of 
SHS because of their higher breathing rate and higher absorp-
tion of pollutants from their lungs (30). Eighteen per cent of the 
smokers in the present survey admitted to smoking indoors when 
there was a child in the house. This result was similar to the find-
ing from a recent study by researchers from the Harvard School 
of Public health (31) in which 20% of children interviewed 
lived with a smoker.
Smoking in cars results in extremely high levels of tobacco 
smoke particles, even with full ventilation and airflow from 
opening all of the windows in a moving vehicle (32). Our sur-
vey showed that 21% of smokers smoked in cars with other 
nonsmokers present, and 8% smoked in the presence of chil-
dren in the car. A Canadian survey from 2007 (33) demon-
strated that 34% of smokers admit to smoking in cars with 
other nonsmokers. Surveys of Canadian children have shown 
that 28% of children in grades 5 to 12 are exposed to SHS in 
cars at least once per week (34). The high percentage of smok-
ers who expose nonsmoking adults and children to SHS in 
Quebec found in this survey was consistent with the results 
from Statistics Canada in 2008 (35) that demonstrated that 
people living in Quebec were more likely to be exposed to SHS 
in the home than Canadians living in other provinces. This is 
especially true for children and teenagers zero to 17 years of 
age, in which 14.5% are regularly exposed to SHS as opposed 
to 8% for the rest of Canada (28). Quebec, together with 
Alberta, Saskatchewan and Newfoundland and Labrador, are 
the only jurisdictions without enforced provincial bylaws ban-
ning smoking in cars with child passengers. 
Study limitations
The results of the present study may have been influenced by 
whether respondents to the telephone or Internet survey were 
truly representative of the population to be investigated. 
Furthermore, differences seen in the awareness of risk for lung 
cancer, COPD and sleep apnea between those at risk and the 
general population may be due to the way the questions were 
posed, or variability in how the data were collected or measured. 
Finally, because of the design of our questions, respondents were 
able to provide a neutral answer, neither agreeing nor disagree-
ing. It was then difficult to know how these people really felt or 
whether their response meant they simply did not know an 
answer. An option of ‘don’t know’ was offered; however, this may 
not have captured all those who fell into that category.
SUMMARy
There needs to be a greater awareness of risk factors by those at 
risk for chronic lung diseases. The lack of awareness of COPD 
in the population most at risk is of particular concern given the 
prevalence and burden of this disease in our society.
Increased public awareness of risk factors for common res-
piratory diseases might help populations understand the poten-
tial consequences of their lifestyle choices on their health, and 
assist them in making appropriate changes or to seek medical 
attention. Public health agencies and the medical community 
need to consider how best to educate the public at risk. The 
Walker et al
Can Respir J Vol 17 No 6 November/December 2010294
results of the present survey may determine what gaps exist in 
awareness for prevalent lung diseases within the Canadian 
population, and lay the foundation to set targets to improve 
awareness of risk factors, symptoms and treatment among at-risk 
groups. The outcomes will help direct future health initiatives 
such as innovative prevention and treatment options, program 
delivery, and research and public awareness campaigns focused 
on these lung disease groups. The present research and analysis, 
and subsequent initiatives will help the CLA at both the 
national and provincial levels, and other stakeholders, to 
achieve a collective goal to improve and promote lung health 
in Canada.
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